Quantifying the carcinogenicity of antineoplastic drugs
- 14 April 1988
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 24 (4) , 703-711
- https://doi.org/10.1016/0277-5379(88)90302-1
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Risk of leukaemia in ovarian tumour and breast cancer patients following treatment by cyclophosphamideBritish Journal of Cancer, 1987
- Acute nonlymphocytic leukemia, preleukemia, and solid tumors following intensive chemotherapy of small cell carcinoma of the lungBlood, 1985
- Risk of Acute Nonlymphocytic Leukemia and Preleukemia in Patients Treated with Cyclophosphamide for Non-Hodgkin's LymphomasAnnals of Internal Medicine, 1985
- Acute Nonlymphocytic Leukemia after Therapy with Alkylating Agents for Ovarian CancerNew England Journal of Medicine, 1982
- Post-therapeutic acute malignant myeloproliferative syndrome and acute nonlymphocytic leukemia in non-Hodgkin's lymphoma correlation with intensity of treatmentCancer, 1982
- Long-term survival in myelomatosis; A REPORT TO THE MRC WORKING PARTY ON LEUKAEMIA IN ADULTSBritish Journal of Haematology, 1982
- Increased Incidence of Acute Leukemia in Polycythemia Vera Associated with Chlorambucil TherapyNew England Journal of Medicine, 1981
- The Chemotherapy of Plasma-Cell Myeloma and the Incidence of Acute LeukemiaNew England Journal of Medicine, 1979
- Acute leukemia after chemotherapy (melphalan)Cancer, 1978
- Risk of new cancers in patients with Hodgkin's diseaseCancer, 1977